InVivo Therapeutics Holdings Corp. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$8.46 |
Market Cap |
$7.26 M |
Shares Outstanding |
9.31 M |
Public Float |
9.28 M |
Address |
One Kendall Square Cambridge Massachusetts 02139 United States |
Employees | - |
Website | http://www.invivotherapeutics.com |
Updated | 07/08/2019 |
Invivo Therapeutics Holdings Corp. operates as a research and clinical-stage biotechnology company, which engages in developing and commercializing biopolymer scaffolding devices for the treatment of SCIs. Its clinical development program is the Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. The company was founded by Joseph P. |